Digitoxigenin structure
|
Common Name | Digitoxigenin | ||
|---|---|---|---|---|
| CAS Number | 143-62-4 | Molecular Weight | 374.514 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 549.3±50.0 °C at 760 mmHg | |
| Molecular Formula | C23H34O4 | Melting Point | 253-255 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | 188.2±23.6 °C | |
| Symbol |
GHS06 |
Signal Word | Danger | |
Use of DigitoxigeninDigitoxigenin is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | digitoxigenin |
|---|---|
| Synonym | More Synonyms |
| Description | Digitoxigenin is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 549.3±50.0 °C at 760 mmHg |
| Melting Point | 253-255 °C (dec.)(lit.) |
| Molecular Formula | C23H34O4 |
| Molecular Weight | 374.514 |
| Flash Point | 188.2±23.6 °C |
| Exact Mass | 374.245697 |
| PSA | 66.76000 |
| LogP | 2.79 |
| Vapour Pressure | 0.0±3.4 mmHg at 25°C |
| Index of Refraction | 1.591 |
| InChIKey | XZTUSOXSLKTKJQ-CESUGQOBSA-N |
| SMILES | CC12CCC(O)CC1CCC1C2CCC2(C)C(C3=CC(=O)OC3)CCC12O |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H300 |
| Precautionary Statements | P264-P301 + P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T |
| Risk Phrases | R25:Toxic if swallowed. |
| Safety Phrases | S45 |
| RIDADR | UN 3462 6.1/PG 2 |
| WGK Germany | 3 |
| RTECS | FH4975000 |
| Packaging Group | II |
| Hazard Class | 6.1(a) |
| Precursor 3 | |
|---|---|
| DownStream 7 | |
|
Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs.
Bioorg. Med. Chem. 19 , 2407-17, (2011) The cardiac glycoside digitoxin, consisting of a steroid core linked to a labile trisaccharide, has been used for centuries for the treatment of congestive heart failure. The well known pharmacologica... |
|
|
C3'/C4'-Stereochemical Effects of Digitoxigenin α-L-/α-D-Glycoside in Cancer Cytotoxicity.
ChemMedChem 8 , 63, (2013) Sweet'n low in stereo: A Wharton reaction was employed along with a diastereoselective palladium-catalyzed glycosylation and other post-glycosylation transformations to synthesize digitoxin analogues.... |
|
|
Assembly of digitoxin by gold(I)-catalyzed glycosidation of glycosyl o-alkynylbenzoates.
J. Org. Chem. 76 , 9748, (2011) Digitoxin, a clinically important cardiac trisaccharide, was assembled efficiently from digitoxigenin and 3,4-di-O-tert-butyldiphenylsilyl-d-digitoxosyl o-cyclopropylethynylbenzoate in 9 steps and 52%... |
| Digitoxigenin |
| 4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2(5H)-furanone |
| EINECS 205-603-4 |
| Echujetin |
| Thevetigenin |
| 3b,14-Dihydroxy-5b-card-20(22)-enolide |
| (3β,5β)-3,14-Dihydroxycard-20(22)-ènolide |
| Cerberigenin |
| D20:22-3,14,21-Trihydroxynorcholenic Acid Lactone |
| 4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-Dihydroxy-10,13-diméthylhexadécahydro-1H-cyclopenta[a]phénanthrén-17-yl]-2(5H)-furanone |
| (3β,5β)-3,14-Dihydroxycard-20(22)-enolide |
| (3b,5b)-3,14-dihydroxycard-20(22)-enolide |
| 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one |
| MFCD00003687 |
| δ20:22-3,14,21-Trihydroxynorcholenic acid lactone |
| 4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2(5H)-furanon |
| Evonogenin |